Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shuji Ohta is active.

Publication


Featured researches published by Shuji Ohta.


Heterocycles | 1994

Concise synthesis of 7,8-dimethoxyisochroman-3-one: formal synthesis of berberine

Isii Hisashi; Hisashi Isii; Mayumi Ozawa; Shuji Ohta; Takashi Harayama; Tsitomu Ishikawa

7,8-Dimethoxyisochroman-3-one (2), a synthetic precursor for berberi- ne, was concisely synthesized from 4-formyl-7-methoxy-2-methylbenzo- [b]furan (3), which had been readily available from isovanillin through the CsF-mediated Claisen rearrangement of the corresponding propargyl ether


Archive | 2000

Substituted pyrazole compounds

Nobuyoshi Minami; Michitaka Sato; Koichi Hasumi; Norio Yamamoto; Katsuyuki Keino; Teruaki Matsui; Arihiro Kanada; Shuji Ohta; Takahisa Saito; Shuichiro Sato; Akira Asagarasu; Satoshi Doi; Motohiro Kobayashi; Jun Sato; Hajime Asano


Archive | 2002

4-(4-pyridazinyl)pyrazole derivatives

Nobuyoshi Minami; Koichi Hasumi; Shuji Ohta; Shuichiro Sato; Takahisa Saito; Satoshi Doi; Motohiro Kobayashi; Jun Sato; Hajime Asano; Yasuhiro Matsumoto


Archive | 2007

Treatment agent for inflammatory bowel disease

Koichi Hasumi; Shuji Ohta; Takahisa Saito; Shuichiro Sato; Jun-ya Kato; Jun Sato; Hiroyuki Suzuki; Hajime Asano; Mami Okada; Yasuhiro Matsumoto; Kazuhiko Shirota


Heterocycles | 2017

An Efficient and Practical Method for the Synthesis of the 5-Acylamino-4-(4-pyrimidinyl)isoxazole Derivative AKP-001, a Potent P38 MAP Kinase Inhibitor

Shuji Ohta; Takahisa Saito; Jun-ya Kato; Shuichiro Sato; Hiroyuki Hayashi; Koichi Hasumi


Archive | 2007

Treating agent of inflammatory bowel disease

Koichi Hasumi; Shuji Ohta; Takahisa Saito; Shuichiro Sato; Jun-ya Kato; Jun Sato; Hiroyuki Suzuki; Hajime Asano; Mami Okada; Yasuhiro Matsumoto; Kazuhiko Shirota


Chemical & Pharmaceutical Bulletin | 1992

Total Synthesis of Lemaireocereine

Hisashi Ishii; Tsutomu Ishikawa; Shuji Ohta; Masahiro Suzuki; Takashi Harayama


Archive | 2007

Agent de traitement pour la maladie intestinale inflammatoire

Koichi Hasumi; Shuji Ohta; Takahisa Saito; Shuichiro Sato; Jun-ya Kato; Jun Sato; Hiroyuki Suzuki; Hajime Asano; Mami Okada; Yasuhiro Matsumoto; Kazuhiko Shirota


Archive | 2002

Derives de 4-(4-pyridazinyl)pyrazole

Nobuyoshi Minami; Koichi Hasumi; Shuji Ohta; Shuichiro Sato; Takahisa Saito; Satoshi Doi; Motohiro Kobayashi; Jun Sato; Hajime Asano; Yasuhiro Matsumoto


Archive | 2000

Substituierte pyrazol-derivate

Akira Asagarasu; Hajime Asano; Satoshi Doi; Koichi Hasumi; Arihiro Kanada; Katsuyuki Keino; Motohiro Kobayashi; Teruaki Matsui; Nobuyoshi Minami; Shuji Ohta; Takahisa Saito; Jun Sato; Michitaka Sato; Shuichiro Sato; Norio Yamamoto

Collaboration


Dive into the Shuji Ohta's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Motohiro Kobayashi

Japanese Foundation for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge